A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 292-299

  McCarty, James M ^a   Richard, George ^b   Huck, Werner ^b   Tucker, Richard M ^b   Tosiello, Robert L ^c   Shan, Michael ^c   Heyd, Allen ^c   Echols, Roger M ^c  

^a Hill Top Research Inc   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE DISEASE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CIPROFLOXACIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; OFLOXACIN; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS;

EID: 0033105747     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00026-1     Document Type: Article

References (20)

1. Boscia J.A., Kaye D. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 1:1987;893-905.
2. Finegold S.M., Miller L.G., Merrill S.L., Posnick D.J. Significance of anaerobic and capnophilic bacteria isolated from the urinary tract. Kass E.H. Progress in Pyelonephritis. 1965;159-178 FA Davis, Philadelphia.
3. Iravani A. Advances in the understanding and treatment of urinary tract infections in young women. Urology. 37:1991;503-511.
4. Rubin R.H., Shapiro E.D., Andriole V.T., et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis. 15:(suppl 1):1992;S216-S227.
5. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. NEJM. 329:1993;1328-1334.
6. Jordan P.A., Iravani A., Richard G.A., Baer H. Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis. 142:1980;510-515.
7. Hooton T.M., Latham R.H., Wong E.S., et al. Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agent Chemother. 33:1989;1308-1312.
8. Basista M.P. Randomized study to evaluate efficacy and safety of ofloxacin vs. trimethoprim and sulfamethoxazole in treatment of uncomplicated urinary tract infection. Urology. 37:(suppl 3):1991;21-27.
9. Hooton T.M., Johnson C., Winter C., et al. Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agent Chemother. 35:1991;1479-1483.
10. Craft J.C., Hurley M., Hsu P., Pernet A. Efficacy and safety of three-day temafloxacin versus seven-day ciprofloxacin therapy in the treatment of uncomplicated urinary tract infections. Eur J Clin Microbiol Infect Dis. (special issue):1991;195-196.
11. Iravani A. Treatment of uncomplicated urinary tract infections with temafloxacin. Am J Med. 91:(suppl 6A):1991;124S-128S.
12. Stein G.E., Phillip E. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women. J Fam Pract. 34:1992;180-184.
13. Iravani A., Tice A.D., McCarty J., et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women the minimum effective dose . Arch Intern Med. 155:1995;485-494.
14. Hooton T.M., Winter C., Tiu F., Stamm W.E. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA. 273:1995;41-45.
15. Lennette E.H., Balows A., Hausler W.J. Jr, Shadomy H.J. Manual of Clinical Microbiology. 5th ed. 1991;American Society for Microbiology, Washington, DC.
16. Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed. 1993;National Committee for Clinical Laboratory Standards, Villanova, Penn.
17. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 2nd ed. 1990;National Committee for Clinical Laboratory Standards, Villanova, Penn.
18. Talan DA, Stamm WE, Reuning-Scherer J, et al. Treatment of acute uncomplicated pyelonephritis (AUP): a randomized double-blind trial comparing 7 vs 14 day therapy. Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 24-28, 1998.
19. Ball P., Tillotson G. Tolerability of quinolone antibiotics past, present, and future . Drug Safety. 13:1995;343-358.
20. Price-chek PC (software). First DataBank, San Bruno, California.